Literature DB >> 19814914

Personalized medicine: a pediatric perspective.

Daniel Arnold, Bridgette L Jones.   

Abstract

The aim of pediatric personalized medicine is to uniquely combine genetic variation with developmental stage and environmental exposure to provide a tailored preventive, diagnostic, and therapeutic regimen. Recent advances in genomic research have identified many genetic variants that may be related to allergic and inflammatory disease and therapeutic response. These include variants involved in immune response, barrier proteins, and medication response. Current evidence also suggests that the effect of genetic variation often depends on the developmental stage of a child and environmental exposure such as infection or tobacco smoke during a specific stage. Personalized medicine is a new and exciting field with the potential to significantly improve medical care for children and adults.

Entities:  

Mesh:

Year:  2009        PMID: 19814914     DOI: 10.1007/s11882-009-0063-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  32 in total

1.  A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.

Authors:  M Baldini; I C Lohman; M Halonen; R P Erickson; P G Holt; F D Martinez
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

2.  Effect of 17q21 variants and smoking exposure in early-onset asthma.

Authors:  Emmanuelle Bouzigon; Eve Corda; Hugues Aschard; Marie-Hélène Dizier; Anne Boland; Jean Bousquet; Nicolas Chateigner; Frédéric Gormand; Jocelyne Just; Nicole Le Moual; Pierre Scheinmann; Valérie Siroux; Daniel Vervloet; Diana Zelenika; Isabelle Pin; Francine Kauffmann; Mark Lathrop; Florence Demenais
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

3.  Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.

Authors:  J M Drazen; C N Yandava; L Dubé; N Szczerback; R Hippensteel; A Pillari; E Israel; N Schork; E S Silverman; D A Katz; J Drajesk
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

4.  Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population.

Authors:  T D Howard; P A Whittaker; A L Zaiman; G H Koppelman; J Xu; M T Hanley; D A Meyers; D S Postma; E R Bleecker
Journal:  Am J Respir Cell Mol Biol       Date:  2001-09       Impact factor: 6.914

5.  Genetic risk for asthma, allergic rhinitis, and atopic dermatitis.

Authors:  S Dold; M Wjst; E von Mutius; P Reitmeir; E Stiepel
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

6.  Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction.

Authors:  Mi-Jin Kang; So-Yeon Lee; Hyo-Bin Kim; Jinho Yu; Byoung-Ju Kim; Won-Ah Choi; Seong-Ok Jang; Soo-Jong Hong
Journal:  Pharmacogenet Genomics       Date:  2008-07       Impact factor: 2.089

7.  The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study.

Authors:  John Henderson; Kate Northstone; Simon P Lee; Haihui Liao; Yiwei Zhao; Marcus Pembrey; Somnath Mukhopadhyay; George Davey Smith; Colin N A Palmer; W H Irwin McLean; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2008-03-05       Impact factor: 10.793

Review 8.  CD14, endotoxin, and asthma risk: actions and interactions.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-07

9.  Genome-wide transcriptional profiling linked to social class in asthma.

Authors:  E Chen; G E Miller; H A Walker; J M Arevalo; C Y Sung; S W Cole
Journal:  Thorax       Date:  2008-11-10       Impact factor: 9.139

10.  Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma.

Authors:  Miriam F Moffatt; Michael Kabesch; Liming Liang; Anna L Dixon; David Strachan; Simon Heath; Martin Depner; Andrea von Berg; Albrecht Bufe; Ernst Rietschel; Andrea Heinzmann; Burkard Simma; Thomas Frischer; Saffron A G Willis-Owen; Kenny C C Wong; Thomas Illig; Christian Vogelberg; Stephan K Weiland; Erika von Mutius; Gonçalo R Abecasis; Martin Farrall; Ivo G Gut; G Mark Lathrop; William O C Cookson
Journal:  Nature       Date:  2007-07-04       Impact factor: 49.962

View more
  1 in total

1.  Personalised medicine in paediatrics: individualising treatment in children with rare neurological diseases.

Authors:  Maurizio Scarpa; Adriana Ceci; Rosella Tomanin; Pierpaolo Mincarone; David Begley
Journal:  EPMA J       Date:  2011-05-01       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.